[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100356796":3},{"organization":4,"outcomesModule":7,"designInfo":14,"detailedDescription":20,"studyPopulation":13,"armGroups":21,"interventions":34,"overallOfficials":44,"centralContacts":57,"locations":63,"responsibleParty":81,"collaborators":13,"id":84,"slug":13,"hasResults":85,"nctId":86,"briefTitle":87,"officialTitle":88,"acronym":13,"eligibilityCriteria":89,"healthyVolunteers":85,"sex":90,"minAge":91,"maxAge":13,"enrollmentInfo":92,"targetDuration":13,"studyType":95,"phases":96,"briefSummary":98,"conditions":99,"keywords":13,"overallStatus":66,"whyStopped":13,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":110},{"fullName":5,"class":6},"Tanta University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":13},[9],{"measure":10,"description":11,"timeFrame":12},"number of patients with tumour response","number of patients with response","6 months",null,{"allocation":15,"interventionModel":16,"interventionModelDescription":13,"primaryPurpose":17,"observationalModel":13,"timePerspective":13,"maskingInfo":18},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":19,"maskingDescription":13,"whoMasked":13},"NONE","mebendazole as adjuvant treatment for colon cancer",[22,28],{"label":23,"type":24,"description":25,"interventionNames":26},"Folfox with avastin","ACTIVE_COMPARATOR","Folfox with avastin only",[27],"Drug: Folfox with avastin",{"label":29,"type":30,"description":31,"interventionNames":32},"Mebendazole","EXPERIMENTAL","Folfox with avastin with mebendazole",[33],"Drug: Mebendazole",[35,40],{"type":36,"name":23,"description":25,"armGroupLabels":37,"otherNames":38},"DRUG",[23],[39],"folfox 4",{"type":36,"name":29,"description":31,"armGroupLabels":41,"otherNames":42},[29],[43],"mebendazol",[45,49,51,54],{"name":46,"affiliation":47,"role":48},"Reham El-ghoneimy, Msc","Tanta University - Faculty of Pharmacy","PRINCIPAL_INVESTIGATOR",{"name":50,"affiliation":47,"role":48},"Sahar Hegazy, Prof",{"name":52,"affiliation":47,"role":53},"Gamal el-azab, Prof","STUDY_DIRECTOR",{"name":55,"affiliation":5,"role":56},"Fatma Zakaria, Prof","STUDY_CHAIR",[58],{"name":59,"role":60,"phone":61,"phoneExt":13,"email":62},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[64],{"facility":65,"status":66,"city":67,"state":13,"zip":13,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":75,"contacts":76},"Sherief Abd-Elsalam","RECRUITING","Cairo","Egypt","EG",{"type":71,"coordinates":72},"Point",[73,74],31.24967,30.06263,{"lat":74,"lon":73},[77],{"name":78,"role":60,"phone":79,"phoneExt":13,"email":80},"Sherief Abd-elsalam, lecturer","00201000040794","Sherif_tropical@yahoo.com",{"type":82,"investigatorFullName":65,"investigatorTitle":83,"investigatorAffiliation":5,"oldNameTitle":13,"oldOrganization":13},"SPONSOR_INVESTIGATOR","Ass. Prof. Tropical Medicine","100356796",false,"NCT03925662","Mebendazole as Adjuvant Treatment for Colon Cancer","Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer","Inclusion Criteria:\n\n* Colorectal cancer stage 4.\n\nExclusion Criteria:\n\n* Agranulocytosis\n* Pregnancy\n* Allergy to mebendazole.","ALL","18 Years",{"count":93,"type":94},40,"ESTIMATED","INTERVENTIONAL",[97],"PHASE3","mebendazole treating colon cancer",[100],"Colorectal Cancer","2019-04-22",{"date":103,"type":104},"2019-04-24","ACTUAL",{"date":106,"type":104},"2019-04-01",{"date":108,"type":94},"2028-12",{"name":65,"class":6},1]